Antibiotic and antifungal use in paediatric departments at three academic hospitals in South Africa

dc.contributor.authorMoore, David P.
dc.contributor.authorChetty, Terusha
dc.contributor.authorPillay, Ashendri
dc.contributor.authorKarsas, Maria
dc.contributor.authorCloete, Jeane
dc.contributor.authorBalakrishna, Yusentha
dc.contributor.authorReddy, Tarylee
dc.contributor.authorArchary, Moherndran
dc.contributor.authorVan Kwawegen, Alison
dc.contributor.authorThomas, Reenu
dc.contributor.authorNakwa, Firdose L.
dc.contributor.authorWaggie, Zainab
dc.contributor.authorMagrath, Stephanie
dc.contributor.authorGoga, Ameena Ebrahim
dc.contributor.authorJeena, Prakash
dc.date.accessioned2024-05-28T12:23:06Z
dc.date.available2024-05-28T12:23:06Z
dc.date.issued2024-03
dc.description.abstractOBJECTIVES : South Africa implemented a National Strategic Framework to optimise antimicrobial stewardship in 2014; however, there is limited data on how this has affected prescribing, especially to children treated in academic centres. METHODS : We conducted a point prevalence survey using the World Health Organization (WHO) methodology to evaluate antibiotic and antifungal prescribing practices in paediatric departments at three academic hospitals in South Africa. RESULTS : We recorded 1946 antimicrobial prescriptions in 1191 children, with 55.2% and 39.2% of the antibiotics classified as WHO AWaRe Access and Watch drugs, respectively. There were significant differences in prescription of Reserve antibiotics and antifungals between institutions. Receipt of WHO Watch and Reserve antibiotics was independently associated with infancy (<12 months) and adolescents (13-17 years) (adjusted relative risk [aRR]: 2.09-9.95); prolonged hospitalisation (aRR: 3.29-30.08); rapidly or ultimately fatal illness (aRR: 1.94 to 5.52); and blood transfusion (aRR: 3.28-5.70). Antifungal prescribing was associated with treatment of hospital-associated infection (aRR: 2.90), medical prophylaxis (aRR: 3.30), and treatment in intensive care units (aRR: 2.15-2.27). CONCLUSIONS : Guidance on optimisation of infection prevention and control practice and strengthening of antimicrobial stewardship would impact positively on the care of sick children in our setting.en_US
dc.description.departmentPaediatrics and Child Healthen_US
dc.description.librarianhj2024en_US
dc.description.sdgSDG-03:Good heatlh and well-beingen_US
dc.description.sponsorshipUNICEF.en_US
dc.description.urihttp://www.elsevier.com/locate/ijregien_US
dc.identifier.citationMoore, D.P., Chetty, T., Pillay, A. et al. 2024, 'Antibiotic and antifungal use in paediatric departments at three academic hospitals in South Africa', IJID Regions, vol. 10, pp. 151-158, doi : 10.1016/j.ijregi.2023.12.004.en_US
dc.identifier.issn2772-7076
dc.identifier.other10.1016/j.ijregi.2023.12.004
dc.identifier.urihttp://hdl.handle.net/2263/96275
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.rights© 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license.en_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.subjectAWaRe classificationen_US
dc.subjectAntimicrobial prescribing auditen_US
dc.subjectHospitalised childrenen_US
dc.subjectAfricaen_US
dc.titleAntibiotic and antifungal use in paediatric departments at three academic hospitals in South Africaen_US
dc.typePostprint Articleen_US

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Moore_Antibiotic_2024.pdf
Size:
1.12 MB
Format:
Adobe Portable Document Format
Description:
Article
Loading...
Thumbnail Image
Name:
Moore_AntibioticSuppl_2024.docx
Size:
438.1 KB
Format:
Microsoft Word XML
Description:
Supplementary Material

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: